When people develop myelodysplastic neoplasms (MDS), the healthy maturation of blood cells is impaired. Severe forms, known as higher-risk MDS, are characterized by rapid progression, severe symptoms and often a transition ...
Jan 22, 2024
0
17
Factors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment fatigue, understanding of the disease, and sources of information, ...
Jan 17, 2024
0
0
A combination of only 11 proteins can predict long-term disability outcomes in multiple sclerosis (MS) for different individuals. The identified proteins could be used to tailor treatments to the individual based on the expected ...
Jan 9, 2024
0
37
Researchers from Rutgers believe themselves among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—the antiviral medication that helps keep high-risk patients out of the hospital ...
Jan 9, 2024
0
15
Researchers at the Scripps Research Institute, Florida, have developed a new method to counteract α-synuclein protein levels by targeting the mRNA that forms them. The strategy unlocks many research doors with potential ...
Chronic liver diseases such as hepatitis, liver cirrhosis, and hepatocellular carcinoma are a major cause of morbidity and mortality worldwide. Fibrosis—the thickening and scarring of connective tissue—plays a major role ...
Jan 8, 2024
0
83
A "chaperone" molecule that slows the formation of certain proteins reversed disease signs, including memory impairment, in a mouse model of Alzheimer's disease, according to a study from researchers at the Perelman School ...
Dec 20, 2023
0
390
The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with immune checkpoint inhibitors (ICIs) had no disease progression two years after discontinuing treatment, ...
Dec 18, 2023
0
2
For transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone induction and consolidation therapy and with ...
Dec 13, 2023
0
8
Researchers at the University of Turku, Finland, have uncovered how the new bexmarilimab therapy alters the function of immune cells so that they can infiltrate the tumor in cancer patients who do not respond to any other ...
Dec 7, 2023
0
128
